LSX Events

To protect the future of healthcare, we need to be data-driven To protect the future of healthcare, we need to be data-driven

byMillie Nelson

Dec 4, 2024

2 Min Read

LSX awards the crème de la crème of dealmaking LSX awards the crème de la crème of dealmaking

byMillie Nelson

Dec 3, 2024

2 Min Read

A whiteboard saying transition

From Series A to B: Navigating the transition from promise to proof

From Series A to B: Navigating the transition from promise to proof

byMillie Nelson, Editor

Chiesi’s partnering success: Confessions of a mid-sized pharma

Chiesi’s partnering success: Confessions of a mid-sized pharma

Picture with women's health written on a card in pink

Call for specific female health funding to tackle biotech finance gender gap

Call for specific female health funding to tackle biotech finance gender gap

byMillie Nelson, Editor

What’s your secret sauce? VC’s on what makes a compelling pitch

VC’s on what makes a compelling pitch

byMillie Nelson, Editor

Business Strategy

Build trust by making healthcare fairer and more equitable, say experts

Build trust by making healthcare fairer and more equitable, say experts

byMillie Nelson, Editor

Trends in biotech investing: time to be cautiously optimistic

Mid-year 2024 trends in biotech investing

different coloured smoke

Business Strategy

Building successful teams in biotech: “The future is female and very colorful”

Building successful teams in biotech

byMillie Nelson, Editor

GSK, Novartis, Calliditas among winners at LSX Awards

GSK, Novartis, Calliditas among winners at LSX Awards

byMillie Nelson, Editor

Subscribe to Our Newsletters

Stay updated and receive your insights for life sciences investment, innovation and partnering directly in your inbox.